Tacedinaline, also known as Acetyldinaline, has been in phase III clinical trials by Pfizer for the treatment of advanced non-small cell lung cancer. Reference standards of Tacedinaline API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Tacedinaline - API Standards [catalogue_number] => PA 20 2950000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 269.3 [form] => C15H15N3O2 [cas] => 112522-64-2 [pslug] => 112522-64-2-tacedinaline-api-pa202950000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 20 2950000
CAS :
Molecular Formula : C15H15N3O2
Molecular Weight : 269.3
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....